Browsing by Author Tang, YF

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 5 to 9 of 9 < previous 
TitleAuthor(s)Issue DateViews
 
A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study
Proceeding/Conference:Journal of Clinical Oncology
Yau, TCCCheung, FYLee, FChoo, SPWong, HYHToh, HCLeung, AKChan, PYau, TKWong, JTang, YFLau, JSMCheung, TTFan, STPoon, RTP
2013
210
 
A new prognostic classification scheme with treatment guidelines for Asian patients with hepatocellular carcinoma (HCC): the Hong Kong Combined Liver Cancer (HKCLC) classification
Proceeding/Conference:Journal of Clinical Oncology
Tang, YFYao, TYau, CCFan, STPoon, RTP
2011
156
 
The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (hcc)
Journal:Oncologist
Wong, HTang, YFYao, TJChiu, JLeung, RChan, PCheung, TTChan, ACPang, RWPoon, RFan, STYau, T
2011
144
 
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: A retrospective analysis of efficacy, safety, and survival benefits
Journal:Cancer
Chiu, JTang, YFYao, TJWong, AWong, HLeung, RChan, PCheung, TTChan, ACPang, RFan, STPoon, RYau, T
2012
158
 
The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis
Proceeding/Conference:Journal of Clinical Oncology
Chiu, JTang, YFYao, TJWong, AWong, HLeung, RChan, PCheung, TTPoon, RTPFan, STYau, CC
2011
139
Showing results 5 to 9 of 9 < previous